The network provides advanced diagnostic services for those Member States that lack diagnostic capability for transmissible encephalopathies and carries out surveillance of variant Creutzfeldt Jakob disease (vCJD) in the EU/EEA.
The EuroCJD meetings are held annually/biannually and constitute a valuable platform for: 1) the assessment of the latest scientific and diagnostic findings and developments in the field of CJD; 2) the assessment of their impact on the needs of future surveillance; and 3) sharing country-specific experience, case studies and public health activities.
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.